Clinical tests were carried out in the representative group of patients with focal left-sided pneumonia (5 men and 7 women aged 18–41). Special-use product was included in in-patient department patients’ diet: 2 tablets in the first intake, then 1 tablet 4 times a day. Course of treatment was 21 days. Biologically active dietary supplement was prescribed together with general therapeutic treatment according to generally accepted standards of care. Control group included 15 patients randomized depending on sex and age who took only medicine. The author measured body temperature, studied the results of general blood tests, determined the level of C-reactive protein and seromucoids, performed R-graphy of lungs, electrocardiogram before and after treatment, analyzed clinical symptoms (cough, type of expectoration, shortness of breath). Composition of the special-use product was scientifically justified taking pharmacological characteristics of its ingredients and their active agents into account. Introduction of the biologically active dietary supplement in addition to the prescribed therapeutic treatment gave positive effect in relation to the inflammatory process: the patients could easier clear their throats from expectoration, coughed less frequently, and had less intense shortness of breath. It was evident that symptoms of disease recrudescence decreased. It appeared in the decreased intensity and length of fever. In case of acute respiratory viral infection the biologically active dietary supplement had antipyretic activity due to the anti-exudative effect of its ingredients. The author determined the anti-inflammatory effect and reduction of acute intoxication symptoms taking the results of general blood analysis into account. Patients who took special-use product had lower values of an inflammatory process marker – seromucoids. Tissues restored easily. The tested product has anti-inflammatory, antipyretic and analgesic properties. It can be used in complex treatment of acute inflammatory diseases and recrudescence of chronic inflammatory processes.

Currently, chocolate and chocolate products remain quite popular among various consumer groups. According to experts, the average Russian consumes 4.7 kg of chocolate and chocolate products per year. The Russian chocolate market is 91% Russian-made. The market offers a wide range of products for various market segments. The high level of competition among the major domestic producers stimulates them to systematically study consumer preferences and adapt to them. In contrast with the central part of Russia, such market novelties as chocolate with salt, pepper, and other specific additives take root quite slowly in the non-metropolitan areas. The present research features the Kemerovo market of chocolate products and the preferences of Kemerovo residents. The main research method was questioning. The study revealed that the main target audience is the economically active female population aged 18–39. The greatest preference is given to milk chocolate in the middle price segment. As for the most preferred chocolate packaging, most respondents singled out plastic and paper packaging. As a rule, chocolate is purchased at a supermarket. Consumers are positive about new products but prefer to buy their favorite types of chocolate. The data obtained allowed the authors to formulate recommendations for chocolate producers taking into account the requirements of the main target audience, their preferences in taste, packaging, and the place of purchase.